Technical Data
E3440-10J
Epstein Barr Virus, Early Antigen, p55, p50 (EBV, Human Herpes virus 4, HHV4)
Description:
The Epstein-Barr virus is the causitive agent of infectious mononucleosis and is associated with two human neoplasms, Burkitt's lymphoma and nasopharyngeal carcinoma. Several EBV-related antigens associated with early or late functions of the viral genome have been identified. The early antigen may be virally or chemically induced in EBV infected cells and is the first detectable marker of EBV infection in human cells.

Applications:
Suitable for use in Immunohistochemistry and Immunoprecipitation.
Other applications not tested.

Recommended Dilution:
Immunocytochemistry: Paraformaldehyde/acetone fixed cell preparations
Optimal dilutions to be determined by the researcher.

Positive Control:
Chemically induced Raji cells

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG11108-1Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceMouse
Concentration:
~0.1mg/ml
Immunogen:
EBV early antigens
Purity:
Purified
Form
Supplied as a liquid in PBS, 0.05% sodium azide.
Specificity:
Recognizes a 55, 50kD polypeptide associated with the early antigen of Epstein-Barr virus (EBV).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Epstein, Alan L.: Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells. J. Virology 50:372-379 (1984).